News

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...
Although new medicines can help you lose weight faster and healthier than ever, a new psychology is needed to keep your ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...